
Fexofenadine Hydrochloride is a highly selective peripheral H1-receptor antagonist. Researchers utilize this API to study the relief of seasonal allergic rhinitis symptoms without the central nervous system effects common in first-generation antihistamines.
In the field of modern immunology, the selective blockade of histamine receptors defines the safety profile of anti-allergy therapeutics. Specifically, Fexofenadine Hydrochloride functions by competing with free histamine for binding sites on H1-receptors in the GI tract, blood vessels, and bronchial smooth muscle. Additionally, researchers select this molecule because its large molecular size and polar nature prevent it from crossing the blood-brain barrier. Therefore, whether you investigate the prevention of mast cell degranulation or develop pediatric suspension formulations, this API delivers reliable pharmacological support across various laboratory conditions.
Zyntex maintains a transparent production chain to ensure a precise impurity profile for every batch, focusing on the limitation of related compounds like the dehydrate form. Moreover, our quality control team verifies every lot for particle size distribution and polymorphic purity to ensure the optimal bioavailability of solid oral dosages. For instance, we optimize the crystalline grade to support the development of 60mg and 180mg tablet formulations used in pharmacodynamic research. As a result, your lab receives a high-purity reagent for advanced studies into the kinetics of receptor binding and the reduction of inflammatory cytokine release.
Modern clinical science relies on high-quality antihistamines to understand the pathophysiology of chronic skin conditions and seasonal allergies. Because Fexofenadine possesses a documented lack of anticholinergic and alpha-adrenergic blocking effects, it remains a primary focus for studies involving long-term safety and cardiovascular stability. Ultimately, Zyntex provides a dependable foundation for your next innovation in respiratory health and specialized pharmaceutical engineering.
This high-selectivity H1-antagonist is vital for the following research and production sectors:
Scientists use Fexofenadine to investigate the suppression of sneezing, rhinorrhea, and itchy eyes in environmental allergen studies.
Researchers include this API in protocols focused on the relief of pruritus and the reduction of wheal and flare reactions in chronic urticaria.
Biotechnicians utilize this molecule as a control to study the exclusion of large, polar molecules from the Central Nervous System.
This compound serves as a core reactant for engineering stable disintegrating tablets and specialized oral liquid formulations.
| Parameter | Specification Standard |
|---|---|
| Product Name | Fexofenadine Hydrochloride (CAS 153439-40-8) |
| Molecular Formula | C32H39NO4 · HCl |
| Purity | USP / BP / EP Grade (Min. 99%) |
| Appearance | White to off-white crystalline powder |
| Solubility | Freely soluble in Methanol; soluble in Ethanol |
🔬 Scientific Data: For detailed pharmacokinetics, P-glycoprotein transport mechanisms, and metabolic studies, consult: PubChem Entry: Fexofenadine Hydrochloride (External Link)